Liquidia (LQDA) Retained Earnings (2019 - 2026)
Liquidia (LQDA) recorded quarterly Retained Earnings of -$573.5 million in Q1 2026, up 8.44% quarter-over-quarter from -$626.3 million in Q4 2025, and up 3.75% on a YoY basis from -$552.7 million in Q1 2025.
Liquidia (LQDA) Retained Earnings (2019 - 2026) Analysis & Trends
Liquidia's Retained Earnings history runs 8 years deep, the most recent figure standing at -$573.5 million for Q1 2026.
- In Q1 2026, Retained Earnings rose 3.75% year-over-year to -$573.5 million; the TTM figure through Mar 2026 stood at -$573.5 million (up 3.75% YoY), while the FY2025 annual figure was -$626.3 million, down 12.37% from the prior year.
- Retained Earnings was -$573.5 million for Q1 2026 at Liquidia, up from -$626.3 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$325.5 million in Q1 2022 to a low of -$640.9 million in Q3 2025.
- Historically, Retained Earnings has averaged -$473.1 million across 5 years, with a median of -$459.2 million in 2024.
- The sharpest annual moves came in 2024 and 2026: Retained Earnings slipped 29.9% in 2024, then grew 3.75% in 2026.
- A 5-year view of Retained Earnings shows it stood at -$350.6 million in 2022, then slipped by 22.39% to -$429.1 million in 2023, then retreated by 29.9% to -$557.4 million in 2024, then dropped by 12.37% to -$626.3 million in 2025, then advanced by 8.44% to -$573.5 million in 2026.
- The last three Retained Earnings figures came in at -$573.5 million (Q1 2026), -$626.3 million (Q4 2025), and -$640.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | -1.87 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -4.41 Mn |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | -573.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -573.45 Mn |
| Dec 31, 2025 | -626.31 Mn |
| Sep 30, 2025 | -640.90 Mn |
| Jun 30, 2025 | -637.34 Mn |
| Mar 31, 2025 | -595.80 Mn |
| Dec 31, 2024 | -557.39 Mn |
| Sep 30, 2024 | -521.10 Mn |
| Jun 30, 2024 | -498.00 Mn |
| Mar 31, 2024 | -459.18 Mn |
| Dec 31, 2023 | -429.10 Mn |
| Sep 30, 2023 | -401.60 Mn |
| Jun 30, 2023 | -385.90 Mn |
| Mar 31, 2023 | -362.30 Mn |
| Dec 31, 2022 | -350.60 Mn |
| Sep 30, 2022 | -344.06 Mn |
| Jun 30, 2022 | -334.97 Mn |
| Mar 31, 2022 | -325.50 Mn |
| Dec 31, 2021 | -309.58 Mn |
| Sep 30, 2021 | -298.00 Mn |
| Jun 30, 2021 | -290.74 Mn |